nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—CYP1A2—schizophrenia	0.253	0.43	CbGaD
Carvedilol—CYP2D6—schizophrenia	0.196	0.332	CbGaD
Carvedilol—ABCB1—schizophrenia	0.14	0.237	CbGaD
Carvedilol—NPPB—blood plasma—schizophrenia	0.00718	0.0503	CbGeAlD
Carvedilol—SELE—blood plasma—schizophrenia	0.00485	0.034	CbGeAlD
Carvedilol—VCAM1—blood plasma—schizophrenia	0.00446	0.0313	CbGeAlD
Carvedilol—NPPB—blood—schizophrenia	0.00263	0.0184	CbGeAlD
Carvedilol—HIF1A—forebrain—schizophrenia	0.00235	0.0165	CbGeAlD
Carvedilol—NPPB—endocrine gland—schizophrenia	0.00228	0.016	CbGeAlD
Carvedilol—GJA1—forebrain—schizophrenia	0.00228	0.016	CbGeAlD
Carvedilol—HIF1A—telencephalon—schizophrenia	0.00216	0.0152	CbGeAlD
Carvedilol—NPPB—nervous system—schizophrenia	0.00214	0.015	CbGeAlD
Carvedilol—GJA1—telencephalon—schizophrenia	0.0021	0.0147	CbGeAlD
Carvedilol—NPPB—central nervous system—schizophrenia	0.00206	0.0144	CbGeAlD
Carvedilol—NDUFC2—forebrain—schizophrenia	0.00199	0.0139	CbGeAlD
Carvedilol—CYP1A2—urine—schizophrenia	0.00196	0.0137	CbGeAlD
Carvedilol—CYP2C9—urine—schizophrenia	0.00186	0.013	CbGeAlD
Carvedilol—NDUFC2—telencephalon—schizophrenia	0.00183	0.0128	CbGeAlD
Carvedilol—HIF1A—gonad—schizophrenia	0.00181	0.0126	CbGeAlD
Carvedilol—SELE—blood—schizophrenia	0.00178	0.0125	CbGeAlD
Carvedilol—CYP2E1—urine—schizophrenia	0.00176	0.0123	CbGeAlD
Carvedilol—SELE—midbrain—schizophrenia	0.00176	0.0123	CbGeAlD
Carvedilol—GJA1—gonad—schizophrenia	0.00175	0.0123	CbGeAlD
Carvedilol—VEGFA—telencephalon—schizophrenia	0.00166	0.0116	CbGeAlD
Carvedilol—VCAM1—blood—schizophrenia	0.00164	0.0115	CbGeAlD
Carvedilol—NPPB—brain—schizophrenia	0.00163	0.0114	CbGeAlD
Carvedilol—VCAM1—midbrain—schizophrenia	0.00161	0.0113	CbGeAlD
Carvedilol—HIF1A—blood—schizophrenia	0.00157	0.011	CbGeAlD
Carvedilol—HIF1A—midbrain—schizophrenia	0.00155	0.0109	CbGeAlD
Carvedilol—SELE—endocrine gland—schizophrenia	0.00154	0.0108	CbGeAlD
Carvedilol—NDUFC2—gonad—schizophrenia	0.00152	0.0107	CbGeAlD
Carvedilol—GJA1—midbrain—schizophrenia	0.00151	0.0106	CbGeAlD
Carvedilol—SELE—nervous system—schizophrenia	0.00144	0.0101	CbGeAlD
Carvedilol—VCAM1—endocrine gland—schizophrenia	0.00142	0.00993	CbGeAlD
Carvedilol—CYP3A4—urine—schizophrenia	0.00142	0.00991	CbGeAlD
Carvedilol—CYP2D6—urine—schizophrenia	0.00139	0.00976	CbGeAlD
Carvedilol—SELE—central nervous system—schizophrenia	0.00139	0.00973	CbGeAlD
Carvedilol—HIF1A—endocrine gland—schizophrenia	0.00136	0.00956	CbGeAlD
Carvedilol—SELE—cerebellum—schizophrenia	0.00136	0.00951	CbGeAlD
Carvedilol—NDUFC2—blood—schizophrenia	0.00133	0.0093	CbGeAlD
Carvedilol—VCAM1—nervous system—schizophrenia	0.00133	0.0093	CbGeAlD
Carvedilol—GJA1—endocrine gland—schizophrenia	0.00132	0.00927	CbGeAlD
Carvedilol—NDUFC2—midbrain—schizophrenia	0.00131	0.00919	CbGeAlD
Carvedilol—VCAM1—central nervous system—schizophrenia	0.00128	0.00895	CbGeAlD
Carvedilol—HIF1A—nervous system—schizophrenia	0.00128	0.00895	CbGeAlD
Carvedilol—GJA1—nervous system—schizophrenia	0.00124	0.00868	CbGeAlD
Carvedilol—HIF1A—central nervous system—schizophrenia	0.00123	0.00861	CbGeAlD
Carvedilol—HIF1A—cerebellum—schizophrenia	0.0012	0.00842	CbGeAlD
Carvedilol—GJA1—central nervous system—schizophrenia	0.00119	0.00835	CbGeAlD
Carvedilol—ADRA1D—forebrain—schizophrenia	0.00118	0.00825	CbGeAlD
Carvedilol—GJA1—cerebellum—schizophrenia	0.00117	0.00817	CbGeAlD
Carvedilol—NDUFC2—endocrine gland—schizophrenia	0.00115	0.00807	CbGeAlD
Carvedilol—SELE—brain—schizophrenia	0.0011	0.00773	CbGeAlD
Carvedilol—ADRA1D—telencephalon—schizophrenia	0.00108	0.00758	CbGeAlD
Carvedilol—NDUFC2—nervous system—schizophrenia	0.00108	0.00755	CbGeAlD
Carvedilol—NDUFC2—central nervous system—schizophrenia	0.00104	0.00727	CbGeAlD
Carvedilol—CYP1A2—blood plasma—schizophrenia	0.00102	0.00715	CbGeAlD
Carvedilol—NDUFC2—cerebellum—schizophrenia	0.00101	0.00711	CbGeAlD
Carvedilol—VCAM1—brain—schizophrenia	0.00101	0.00711	CbGeAlD
Carvedilol—HIF1A—brain—schizophrenia	0.000976	0.00684	CbGeAlD
Carvedilol—CYP2C9—blood plasma—schizophrenia	0.000969	0.00679	CbGeAlD
Carvedilol—GJA1—brain—schizophrenia	0.000947	0.00663	CbGeAlD
Carvedilol—ADRA2A—blood plasma—schizophrenia	0.000938	0.00657	CbGeAlD
Carvedilol—XDH—endocrine gland—schizophrenia	0.00093	0.00652	CbGeAlD
Carvedilol—Bopindolol—HTR1B—schizophrenia	0.000926	0.124	CrCbGaD
Carvedilol—VEGFA—cerebellum—schizophrenia	0.000921	0.00645	CbGeAlD
Carvedilol—Tamsulosin—HTR7—schizophrenia	0.00092	0.123	CrCbGaD
Carvedilol—CYP2E1—blood plasma—schizophrenia	0.000918	0.00643	CbGeAlD
Carvedilol—PTGS1—blood plasma—schizophrenia	0.000884	0.00619	CbGeAlD
Carvedilol—Tamsulosin—DRD3—schizophrenia	0.000865	0.116	CrCbGaD
Carvedilol—ADRB1—forebrain—schizophrenia	0.000855	0.00599	CbGeAlD
Carvedilol—NDUFC2—brain—schizophrenia	0.000824	0.00577	CbGeAlD
Carvedilol—ADRB1—telencephalon—schizophrenia	0.000786	0.00551	CbGeAlD
Carvedilol—VEGFA—brain—schizophrenia	0.000748	0.00524	CbGeAlD
Carvedilol—CYP3A4—blood plasma—schizophrenia	0.000739	0.00517	CbGeAlD
Carvedilol—Bopindolol—HTR1A—schizophrenia	0.000733	0.0983	CrCbGaD
Carvedilol—CYP2D6—blood plasma—schizophrenia	0.000727	0.00509	CbGeAlD
Carvedilol—Tamsulosin—HTR1A—schizophrenia	0.000705	0.0946	CrCbGaD
Carvedilol—ADRA1D—endocrine gland—schizophrenia	0.000683	0.00478	CbGeAlD
Carvedilol—ADRA1A—forebrain—schizophrenia	0.000676	0.00474	CbGeAlD
Carvedilol—ADRA1B—nervous system—schizophrenia	0.000653	0.00458	CbGeAlD
Carvedilol—KCNH2—forebrain—schizophrenia	0.000653	0.00457	CbGeAlD
Carvedilol—ADRA1D—nervous system—schizophrenia	0.000639	0.00448	CbGeAlD
Carvedilol—ADRA1B—central nervous system—schizophrenia	0.000629	0.00441	CbGeAlD
Carvedilol—ADRA1A—telencephalon—schizophrenia	0.000622	0.00436	CbGeAlD
Carvedilol—ADRA1D—central nervous system—schizophrenia	0.000615	0.00431	CbGeAlD
Carvedilol—KCNH2—telencephalon—schizophrenia	0.0006	0.00421	CbGeAlD
Carvedilol—Tamsulosin—DRD2—schizophrenia	0.000599	0.0803	CrCbGaD
Carvedilol—ADRA2C—telencephalon—schizophrenia	0.000592	0.00415	CbGeAlD
Carvedilol—ABCB1—blood plasma—schizophrenia	0.000523	0.00366	CbGeAlD
Carvedilol—ADRA2A—forebrain—schizophrenia	0.000514	0.0036	CbGeAlD
Carvedilol—ADRA1B—brain—schizophrenia	0.000499	0.0035	CbGeAlD
Carvedilol—ADRB1—endocrine gland—schizophrenia	0.000496	0.00347	CbGeAlD
Carvedilol—ADRA1D—brain—schizophrenia	0.000488	0.00342	CbGeAlD
Carvedilol—PTGS1—forebrain—schizophrenia	0.000485	0.00339	CbGeAlD
Carvedilol—ADRA2A—telencephalon—schizophrenia	0.000473	0.00331	CbGeAlD
Carvedilol—ADRB1—nervous system—schizophrenia	0.000464	0.00325	CbGeAlD
Carvedilol—CYP2E1—telencephalon—schizophrenia	0.000462	0.00324	CbGeAlD
Carvedilol—ADRA1A—blood—schizophrenia	0.000452	0.00317	CbGeAlD
Carvedilol—ADRB1—central nervous system—schizophrenia	0.000447	0.00313	CbGeAlD
Carvedilol—PTGS1—telencephalon—schizophrenia	0.000446	0.00312	CbGeAlD
Carvedilol—Ranolazine—CYP2D6—schizophrenia	0.00044	0.059	CrCbGaD
Carvedilol—KCNH2—blood—schizophrenia	0.000437	0.00306	CbGeAlD
Carvedilol—KCNH2—midbrain—schizophrenia	0.000431	0.00302	CbGeAlD
Carvedilol—ADRA2C—blood—schizophrenia	0.000431	0.00302	CbGeAlD
Carvedilol—ADRA2C—midbrain—schizophrenia	0.000425	0.00298	CbGeAlD
Carvedilol—Tamsulosin—CYP2D6—schizophrenia	0.000423	0.0568	CrCbGaD
Carvedilol—CYP2D6—forebrain—schizophrenia	0.000398	0.00279	CbGeAlD
Carvedilol—ADRA2A—gonad—schizophrenia	0.000395	0.00276	CbGeAlD
Carvedilol—ADRA1A—endocrine gland—schizophrenia	0.000392	0.00275	CbGeAlD
Carvedilol—KCNH2—endocrine gland—schizophrenia	0.000379	0.00265	CbGeAlD
Carvedilol—CYP1A2—blood—schizophrenia	0.000374	0.00262	CbGeAlD
Carvedilol—CYP1A1—blood—schizophrenia	0.000369	0.00258	CbGeAlD
Carvedilol—ADRA1A—nervous system—schizophrenia	0.000367	0.00257	CbGeAlD
Carvedilol—CYP2D6—telencephalon—schizophrenia	0.000366	0.00256	CbGeAlD
Carvedilol—CYP2C9—blood—schizophrenia	0.000355	0.00249	CbGeAlD
Carvedilol—ADRB1—brain—schizophrenia	0.000355	0.00249	CbGeAlD
Carvedilol—KCNH2—nervous system—schizophrenia	0.000355	0.00248	CbGeAlD
Carvedilol—ADRA1A—central nervous system—schizophrenia	0.000353	0.00248	CbGeAlD
Carvedilol—ADRA2C—nervous system—schizophrenia	0.00035	0.00245	CbGeAlD
Carvedilol—Propranolol—HTR1B—schizophrenia	0.000347	0.0466	CrCbGaD
Carvedilol—ADRA1A—cerebellum—schizophrenia	0.000345	0.00242	CbGeAlD
Carvedilol—ADRA2A—blood—schizophrenia	0.000344	0.00241	CbGeAlD
Carvedilol—KCNH2—central nervous system—schizophrenia	0.000341	0.00239	CbGeAlD
Carvedilol—ADRA2A—midbrain—schizophrenia	0.000339	0.00238	CbGeAlD
Carvedilol—ADRA2C—central nervous system—schizophrenia	0.000337	0.00236	CbGeAlD
Carvedilol—CYP2E1—blood—schizophrenia	0.000336	0.00236	CbGeAlD
Carvedilol—KCNH2—cerebellum—schizophrenia	0.000334	0.00234	CbGeAlD
Carvedilol—ADRA2C—cerebellum—schizophrenia	0.000329	0.00231	CbGeAlD
Carvedilol—CYP1A2—endocrine gland—schizophrenia	0.000324	0.00227	CbGeAlD
Carvedilol—PTGS1—blood—schizophrenia	0.000324	0.00227	CbGeAlD
Carvedilol—CYP1A1—endocrine gland—schizophrenia	0.00032	0.00224	CbGeAlD
Carvedilol—Propafenone—CYP1A2—schizophrenia	0.000312	0.0419	CrCbGaD
Carvedilol—CYP2C9—endocrine gland—schizophrenia	0.000308	0.00216	CbGeAlD
Carvedilol—CYP1A1—nervous system—schizophrenia	0.000299	0.0021	CbGeAlD
Carvedilol—ADRA2A—endocrine gland—schizophrenia	0.000298	0.00209	CbGeAlD
Carvedilol—CYP2E1—endocrine gland—schizophrenia	0.000292	0.00204	CbGeAlD
Carvedilol—CYP1A1—central nervous system—schizophrenia	0.000288	0.00202	CbGeAlD
Carvedilol—ABCB1—forebrain—schizophrenia	0.000286	0.00201	CbGeAlD
Carvedilol—PTGS1—endocrine gland—schizophrenia	0.000281	0.00197	CbGeAlD
Carvedilol—ADRA1A—brain—schizophrenia	0.000281	0.00197	CbGeAlD
Carvedilol—ADRA2A—nervous system—schizophrenia	0.000279	0.00195	CbGeAlD
Carvedilol—Propranolol—HTR1A—schizophrenia	0.000275	0.0369	CrCbGaD
Carvedilol—CYP2E1—nervous system—schizophrenia	0.000273	0.00191	CbGeAlD
Carvedilol—KCNH2—brain—schizophrenia	0.000271	0.0019	CbGeAlD
Carvedilol—CYP3A4—blood—schizophrenia	0.000271	0.0019	CbGeAlD
Carvedilol—ADRA2A—central nervous system—schizophrenia	0.000269	0.00188	CbGeAlD
Carvedilol—ADRA2C—brain—schizophrenia	0.000267	0.00187	CbGeAlD
Carvedilol—CYP2D6—blood—schizophrenia	0.000266	0.00187	CbGeAlD
Carvedilol—ABCB1—telencephalon—schizophrenia	0.000263	0.00185	CbGeAlD
Carvedilol—PTGS1—nervous system—schizophrenia	0.000263	0.00184	CbGeAlD
Carvedilol—CYP2E1—central nervous system—schizophrenia	0.000263	0.00184	CbGeAlD
Carvedilol—ADRA2A—cerebellum—schizophrenia	0.000263	0.00184	CbGeAlD
Carvedilol—CYP2E1—cerebellum—schizophrenia	0.000257	0.0018	CbGeAlD
Carvedilol—PTGS1—central nervous system—schizophrenia	0.000253	0.00177	CbGeAlD
Carvedilol—Propafenone—CYP2D6—schizophrenia	0.000241	0.0323	CrCbGaD
Carvedilol—CYP3A4—endocrine gland—schizophrenia	0.000235	0.00164	CbGeAlD
Carvedilol—CYP2D6—endocrine gland—schizophrenia	0.000231	0.00162	CbGeAlD
Carvedilol—CYP1A1—brain—schizophrenia	0.000229	0.0016	CbGeAlD
Carvedilol—ABCB1—gonad—schizophrenia	0.00022	0.00154	CbGeAlD
Carvedilol—CYP3A4—nervous system—schizophrenia	0.00022	0.00154	CbGeAlD
Carvedilol—CYP2D6—nervous system—schizophrenia	0.000216	0.00151	CbGeAlD
Carvedilol—Propranolol—CYP1A2—schizophrenia	0.000214	0.0287	CrCbGaD
Carvedilol—ADRA2A—brain—schizophrenia	0.000213	0.00149	CbGeAlD
Carvedilol—CYP3A4—central nervous system—schizophrenia	0.000212	0.00148	CbGeAlD
Carvedilol—CYP2E1—brain—schizophrenia	0.000209	0.00146	CbGeAlD
Carvedilol—CYP2D6—central nervous system—schizophrenia	0.000208	0.00146	CbGeAlD
Carvedilol—CYP2D6—cerebellum—schizophrenia	0.000203	0.00142	CbGeAlD
Carvedilol—PTGS1—brain—schizophrenia	0.000201	0.00141	CbGeAlD
Carvedilol—ABCB1—blood—schizophrenia	0.000192	0.00134	CbGeAlD
Carvedilol—ABCB1—midbrain—schizophrenia	0.000189	0.00133	CbGeAlD
Carvedilol—Propafenone—ABCB1—schizophrenia	0.000172	0.0231	CrCbGaD
Carvedilol—ABCB1—endocrine gland—schizophrenia	0.000166	0.00116	CbGeAlD
Carvedilol—CYP2D6—brain—schizophrenia	0.000165	0.00116	CbGeAlD
Carvedilol—Propranolol—CYP2D6—schizophrenia	0.000165	0.0221	CrCbGaD
Carvedilol—ABCB1—nervous system—schizophrenia	0.000156	0.00109	CbGeAlD
Carvedilol—ABCB1—central nervous system—schizophrenia	0.00015	0.00105	CbGeAlD
Carvedilol—ABCB1—cerebellum—schizophrenia	0.000146	0.00103	CbGeAlD
Carvedilol—ABCB1—brain—schizophrenia	0.000119	0.000833	CbGeAlD
Carvedilol—Propranolol—ABCB1—schizophrenia	0.000118	0.0158	CrCbGaD
Carvedilol—ADRB1—Signaling Pathways—ERBB3—schizophrenia	5.42e-06	2.08e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CLOCK—schizophrenia	5.42e-06	2.08e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	5.4e-06	2.07e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—schizophrenia	5.4e-06	2.07e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TPH1—schizophrenia	5.38e-06	2.06e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCLM—schizophrenia	5.38e-06	2.06e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ERBB3—schizophrenia	5.37e-06	2.06e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PLA2G4A—schizophrenia	5.37e-06	2.06e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APOE—schizophrenia	5.37e-06	2.06e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APOE—schizophrenia	5.36e-06	2.05e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NRG1—schizophrenia	5.35e-06	2.05e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	5.34e-06	2.05e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APOE—schizophrenia	5.32e-06	2.04e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—COMT—schizophrenia	5.32e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MEF2C—schizophrenia	5.31e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—APOA1—schizophrenia	5.31e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—S100B—schizophrenia	5.3e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	5.3e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PLA2G4A—schizophrenia	5.3e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GSTM1—schizophrenia	5.3e-06	2.03e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—APOA1—schizophrenia	5.3e-06	2.03e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GSTP1—schizophrenia	5.3e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PRL—schizophrenia	5.29e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP2D6—schizophrenia	5.29e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SNAP25—schizophrenia	5.29e-06	2.03e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MAOA—schizophrenia	5.28e-06	2.02e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TPH2—schizophrenia	5.28e-06	2.02e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CACNB2—schizophrenia	5.28e-06	2.02e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NRG1—schizophrenia	5.27e-06	2.02e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APOA1—schizophrenia	5.26e-06	2.02e-05	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—AKT1—schizophrenia	5.24e-06	2.01e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MEF2C—schizophrenia	5.22e-06	2e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HTR2A—schizophrenia	5.22e-06	2e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—DPYD—schizophrenia	5.19e-06	1.99e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HTR2A—schizophrenia	5.17e-06	1.98e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—YWHAZ—schizophrenia	5.13e-06	1.97e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	5.1e-06	1.95e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ESR1—schizophrenia	5.08e-06	1.95e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ERBB4—schizophrenia	5.07e-06	1.94e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PRKD1—schizophrenia	5.05e-06	1.94e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—YWHAZ—schizophrenia	5.05e-06	1.93e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ERBB3—schizophrenia	5.02e-06	1.92e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—COMT—schizophrenia	5.02e-06	1.92e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ABCB1—schizophrenia	5.01e-06	1.92e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTP1—schizophrenia	4.99e-06	1.91e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SNAP25—schizophrenia	4.98e-06	1.91e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MAOA—schizophrenia	4.98e-06	1.91e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP2D6—schizophrenia	4.94e-06	1.89e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SNAP25—schizophrenia	4.94e-06	1.89e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ERBB3—schizophrenia	4.94e-06	1.89e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—S100B—schizophrenia	4.93e-06	1.89e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—AKT1—schizophrenia	4.88e-06	1.87e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PLA2G4A—schizophrenia	4.87e-06	1.86e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GSTM1—schizophrenia	4.87e-06	1.86e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APOE—schizophrenia	4.85e-06	1.86e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.83e-06	1.85e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CACNA1C—schizophrenia	4.83e-06	1.85e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HTR2A—schizophrenia	4.83e-06	1.85e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APOE—schizophrenia	4.8e-06	1.84e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APOA1—schizophrenia	4.79e-06	1.84e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP1A2—schizophrenia	4.78e-06	1.83e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PLA2G4A—schizophrenia	4.77e-06	1.83e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—AKT1—schizophrenia	4.76e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HTR2A—schizophrenia	4.75e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APOA1—schizophrenia	4.75e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APOE—schizophrenia	4.74e-06	1.82e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ABCB1—schizophrenia	4.73e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ERBB4—schizophrenia	4.71e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TH—schizophrenia	4.71e-06	1.81e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3C2A—schizophrenia	4.7e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APOA1—schizophrenia	4.69e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—MTHFR—schizophrenia	4.68e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NRG1—schizophrenia	4.68e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—EP300—schizophrenia	4.66e-06	1.78e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—EP300—schizophrenia	4.65e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MEF2C—schizophrenia	4.64e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ESR1—schizophrenia	4.63e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—GSK3B—schizophrenia	4.61e-06	1.77e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTM1—schizophrenia	4.59e-06	1.76e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PLA2G4A—schizophrenia	4.59e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ESR1—schizophrenia	4.59e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—AKT1—schizophrenia	4.56e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ESR1—schizophrenia	4.53e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP1A2—schizophrenia	4.51e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOE—schizophrenia	4.49e-06	1.72e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—YWHAZ—schizophrenia	4.48e-06	1.72e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP1A2—schizophrenia	4.47e-06	1.71e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TH—schizophrenia	4.44e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APOA1—schizophrenia	4.44e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PLA2G4A—schizophrenia	4.43e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOE—schizophrenia	4.42e-06	1.69e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TH—schizophrenia	4.4e-06	1.69e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—schizophrenia	4.39e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ERBB3—schizophrenia	4.38e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APOA1—schizophrenia	4.37e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOE—schizophrenia	4.36e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NRG1—schizophrenia	4.35e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MEF2C—schizophrenia	4.31e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—APOA1—schizophrenia	4.31e-06	1.65e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—MTHFR—schizophrenia	4.3e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ESR1—schizophrenia	4.28e-06	1.64e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—schizophrenia	4.22e-06	1.62e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP2D6—schizophrenia	4.22e-06	1.62e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SNAP25—schizophrenia	4.22e-06	1.62e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GAPDH—schizophrenia	4.22e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ESR1—schizophrenia	4.22e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—GSK3B—schizophrenia	4.2e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CLOCK—schizophrenia	4.18e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—YWHAZ—schizophrenia	4.17e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—GSK3B—schizophrenia	4.16e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	4.11e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ERBB3—schizophrenia	4.07e-06	1.56e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TPH2—schizophrenia	4.07e-06	1.56e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CACNB2—schizophrenia	4.07e-06	1.56e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTHFR—schizophrenia	4.05e-06	1.55e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—DPYD—schizophrenia	4.01e-06	1.54e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—COMT—schizophrenia	4.01e-06	1.53e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—schizophrenia	4e-06	1.53e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTP1—schizophrenia	3.99e-06	1.53e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MAOA—schizophrenia	3.98e-06	1.52e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOA1—schizophrenia	3.96e-06	1.52e-05	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AKT1—schizophrenia	3.94e-06	1.51e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—schizophrenia	3.92e-06	1.5e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—schizophrenia	3.92e-06	1.5e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—GSK3B—schizophrenia	3.89e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOA1—schizophrenia	3.88e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—GSK3B—schizophrenia	3.83e-06	1.47e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—COMT—schizophrenia	3.78e-06	1.45e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—schizophrenia	3.77e-06	1.45e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TH—schizophrenia	3.76e-06	1.44e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTP1—schizophrenia	3.76e-06	1.44e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MAOA—schizophrenia	3.75e-06	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ESR1—schizophrenia	3.75e-06	1.44e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—COMT—schizophrenia	3.74e-06	1.43e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOA1—schizophrenia	3.73e-06	1.43e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CACNA1C—schizophrenia	3.73e-06	1.43e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTP1—schizophrenia	3.72e-06	1.43e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MAOA—schizophrenia	3.72e-06	1.42e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—AKT1—schizophrenia	3.7e-06	1.42e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PLA2G4A—schizophrenia	3.66e-06	1.4e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTM1—schizophrenia	3.66e-06	1.4e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—schizophrenia	3.65e-06	1.4e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3C2A—schizophrenia	3.63e-06	1.39e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.6e-06	1.38e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOA1—schizophrenia	3.6e-06	1.38e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ABCB1—schizophrenia	3.56e-06	1.36e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ABCB1—schizophrenia	3.53e-06	1.35e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ESR1—schizophrenia	3.48e-06	1.33e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3.45e-06	1.32e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTM1—schizophrenia	3.45e-06	1.32e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PLA2G4A—schizophrenia	3.42e-06	1.31e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTM1—schizophrenia	3.42e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AKT1—schizophrenia	3.42e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GSK3B—schizophrenia	3.4e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—schizophrenia	3.33e-06	1.28e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—schizophrenia	3.32e-06	1.27e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SNAP25—schizophrenia	3.26e-06	1.25e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2D6—schizophrenia	3.26e-06	1.25e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—schizophrenia	3.24e-06	1.24e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—COMT—schizophrenia	3.2e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTP1—schizophrenia	3.18e-06	1.22e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MAOA—schizophrenia	3.18e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GSK3B—schizophrenia	3.16e-06	1.21e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	3.11e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—schizophrenia	3.1e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—schizophrenia	3.08e-06	1.18e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.08e-06	1.18e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—EP300—schizophrenia	3.06e-06	1.17e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—EP300—schizophrenia	3.05e-06	1.17e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—schizophrenia	3.05e-06	1.17e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	3.05e-06	1.17e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EP300—schizophrenia	3.03e-06	1.16e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—schizophrenia	3.03e-06	1.16e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—schizophrenia	3.01e-06	1.16e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ABCB1—schizophrenia	3.01e-06	1.15e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOA1—schizophrenia	2.98e-06	1.14e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP1A2—schizophrenia	2.95e-06	1.13e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTM1—schizophrenia	2.93e-06	1.12e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PLA2G4A—schizophrenia	2.93e-06	1.12e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TH—schizophrenia	2.9e-06	1.11e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—schizophrenia	2.88e-06	1.1e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—schizophrenia	2.84e-06	1.09e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—schizophrenia	2.84e-06	1.09e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—schizophrenia	2.83e-06	1.08e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—schizophrenia	2.82e-06	1.08e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—schizophrenia	2.81e-06	1.08e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOA1—schizophrenia	2.81e-06	1.08e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—schizophrenia	2.81e-06	1.08e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—schizophrenia	2.8e-06	1.07e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOA1—schizophrenia	2.78e-06	1.07e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	2.77e-06	1.06e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EP300—schizophrenia	2.76e-06	1.06e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EP300—schizophrenia	2.74e-06	1.05e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EP300—schizophrenia	2.7e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—schizophrenia	2.62e-06	1e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—schizophrenia	2.59e-06	9.9e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—schizophrenia	2.58e-06	9.87e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EP300—schizophrenia	2.56e-06	9.8e-06	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—schizophrenia	2.52e-06	9.65e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EP300—schizophrenia	2.52e-06	9.64e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—EP300—schizophrenia	2.48e-06	9.52e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—COMT—schizophrenia	2.47e-06	9.46e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTP1—schizophrenia	2.46e-06	9.41e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MAOA—schizophrenia	2.45e-06	9.39e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—schizophrenia	2.41e-06	9.22e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOA1—schizophrenia	2.38e-06	9.12e-06	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—schizophrenia	2.34e-06	8.97e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCB1—schizophrenia	2.33e-06	8.91e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—schizophrenia	2.29e-06	8.76e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—EP300—schizophrenia	2.28e-06	8.74e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTM1—schizophrenia	2.26e-06	8.65e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PLA2G4A—schizophrenia	2.26e-06	8.65e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EP300—schizophrenia	2.24e-06	8.57e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—schizophrenia	2.17e-06	8.32e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—EP300—schizophrenia	2.15e-06	8.24e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—schizophrenia	2.13e-06	8.14e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EP300—schizophrenia	2.08e-06	7.96e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—schizophrenia	2e-06	7.64e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—schizophrenia	1.98e-06	7.58e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—schizophrenia	1.96e-06	7.51e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—schizophrenia	1.93e-06	7.41e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—schizophrenia	1.86e-06	7.12e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—schizophrenia	1.85e-06	7.08e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—schizophrenia	1.84e-06	7.07e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOA1—schizophrenia	1.84e-06	7.03e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—schizophrenia	1.83e-06	7.02e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—schizophrenia	1.83e-06	7.01e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—schizophrenia	1.8e-06	6.9e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—EP300—schizophrenia	1.72e-06	6.58e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—schizophrenia	1.67e-06	6.4e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—schizophrenia	1.65e-06	6.34e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—schizophrenia	1.63e-06	6.26e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—EP300—schizophrenia	1.62e-06	6.2e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—EP300—schizophrenia	1.6e-06	6.15e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—schizophrenia	1.6e-06	6.13e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—schizophrenia	1.55e-06	5.92e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—schizophrenia	1.52e-06	5.83e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—schizophrenia	1.5e-06	5.75e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—schizophrenia	1.49e-06	5.7e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—schizophrenia	1.38e-06	5.28e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—EP300—schizophrenia	1.37e-06	5.25e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—schizophrenia	1.35e-06	5.18e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—schizophrenia	1.3e-06	4.98e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—schizophrenia	1.26e-06	4.81e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—EP300—schizophrenia	1.06e-06	4.06e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—schizophrenia	1.04e-06	3.98e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—schizophrenia	9.78e-07	3.75e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—schizophrenia	9.7e-07	3.72e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—schizophrenia	8.29e-07	3.18e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—schizophrenia	6.4e-07	2.45e-06	CbGpPWpGaD
